Clinical Trial Update: JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating JS207 in combination with chemotherapy as first-line treatment for advanced non-small cell lung cancer, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• JS207

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING